Answers are grounded in this paper and cite their sources.
Evaluates acyclic nucleotide analogues for antiviral activity, highlighting their inactivity against tested viruses.
As a part of a broader structure–activity relationship (SAR) study of bicyclic nucleoside analogues (BCNAs) [anti-varicella-zoster virus (anti-VZV) and anti-human cytomegalovirus (anti-HCMV) agents], a novel series of 2-(phosphonomethoxy)ethyl (PME) substituted furo[2,3-d]pyrimidin-2(3H)-ones was synthesized. The target acyclic nucleotide analogues were prepared by Sonogashira coupling of protected 5-iodo-1-[2-(phosphonomethoxy)ethyl]uracil with various 1-alkynes, followed by in situ Cu(I)-promoted intramolecular cyclization and standard removal of the isopropyl ester groups. None of the prepared PME analogues were active at subtoxic concentrations against VZV thymidine kinase competent (TK + ), VZV thymidine kinase deficient (TK – ), HCMV, or any other viruses tested.
No takes yet. Share an insight, caveat, or question.
Janeba et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: